SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Lindman Kristina)
 

Search: WFRF:(Lindman Kristina) > Long-term outcome i...

Long-term outcome in young women with breast cancer : a population-based study

Fredholm, Hanna (author)
Karolinska Institutet
Magnusson, Kristina (author)
Uppsala universitet,Institutionen för immunologi, genetik och patologi,Science for Life Laboratory, SciLifeLab
Lindström, Linda S. (author)
Karolinska Institutet
show more...
Garmo, Hans (author)
Uppsala universitet,Institutionen för kirurgiska vetenskaper,Kings Coll London, Fac Life Sci & Med, Div Canc Studies, London, England.
Fält, Sonja Eaker (author)
Uppsala universitet,Endokrinkirurgi
Lindman, Henrik (author)
Uppsala universitet,Institutionen för radiologi, onkologi och strålningsvetenskap
Bergh, Jonas (author)
Karolinska Institutet
Holmberg, Lars (author)
Uppsala universitet,Endokrinkirurgi,Kings Coll London, Fac Life Sci & Med, Div Canc Studies, London, England.
Pontén, Fredrik (author)
Uppsala universitet,Institutionen för immunologi, genetik och patologi,Science for Life Laboratory, SciLifeLab
Frisell, Jan (author)
Karolinska Institutet
Fredriksson, Irma (author)
Karolinska Institutet
show less...
 (creator_code:org_t)
2016-09-13
2016
English.
In: Breast Cancer Research and Treatment. - : Springer Science and Business Media LLC. - 0167-6806 .- 1573-7217. ; 160:1, s. 131-143
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Whether young age at diagnosis of breast cancer is an independent risk factor for death remains controversial, and the question whether young age should be considered in treatment decisions is still to be answered. From a population-based cohort of 22,017 women with breast cancer, all women < 35 years (n = 471) were compared to a random sample of 700 women aged 35-69 years from the same cohort. Information on patient and tumor characteristics, treatment, and follow-up was collected from the medical records. Tissue microarrays were produced for analysis of classical biomarkers. Breast cancer-specific survival (BCSS), distant disease-free survival (DDFS), and locoregional recurrence-free survival (LRFS) by age were compared using women 50-69 years as reference. At 10 years follow-up, women < 35 years and 35-39 years had a worse BCSS [age < 35 years 69 % (HR 2.75, 95 % CI 1.93-3.94), age 35-39 years 76 % (HR 2.33, 95 % CI 1.54-3.52), age 40-49 years 84 % (HR 1.53, 95 % CI 0.97-2.39), and age 50-69 years 89 % (reference)]. The worse BCSS was statistically significant in stages I-IIa and Luminal B tumors. At multivariate analysis age < 35 years and 35-39 years confined a risk in LRFS (HR 2.13, 95 % CI 1.21-3.76 and HR 1.97, 95 % CI 1.06-3.68) but not in DDFS and BCSS. In the subgroup of women < 40 years with luminal tumors stage I-IIa, low age remained an independent risk factor also in DDFS (HR 1.87, 95 % CI 1.03-3.44). Young women have a high risk of systemic disease even when diagnosed in an early stage. The excess risk of relapse is most pronounced in Luminal B tumors, where low age is an independent prognostic factor of DDFS and LRFS.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Keyword

Breast cancer
Young age
Subtype
Luminal B
Early stage
Prognosis
Population-based

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view